Sigma Nutrition Radio #594: Can Muscle Still Adapt Positively When Training Under Low Energy Availability? – Jose Areta, PhD
George’s Podcast Reflection Notes.
All these clips and short segments are made with the help of Snipd, the AI-powered podcast app for knowledge seekers.
Energy Deficit Triggers Complex Adaptive Muscle Changes
Short-term low energy availability downregulates some collagen proteins while increasing dystrophin-associated proteins, indicating structural remodeling rather than simple damage.
Areta argues this may be an adaptive trade-off for immediate survival and needs careful interpretation before labeling it harmful.
Energy Deficit Acts As a Stressor Driving Adaptation
Jose Areta says short energy deficits can act as a stressor that elicits adaptive responses rather than simply causing muscle shutdown.
He cautions dosage matters: a little may be beneficial, too much can be harmful; more research needed on practical use for athletes.
Energy Deficit Can Be a Stressor That Drives Mixed Adaptations
Jose Areta says short energy deficits act as a stressor that can generate adaptations rather than just shutdown.
Some systems (e.g., mitochondrial proteins) may adapt positively while others show negative responses, especially in elite sport.
Muscle Can Still Adapt During Short Energy Deficits
Muscles continued to adapt and performance improved despite an unintended energy deficit during an eight-day race.
The athlete consumed ~14 g/kg carbs daily, lost ~2 kg, yet power output increased throughout the race.
Muscle Can Still Adapt During Energy Deficit
Muscle physiology can continue adapting positively during an energy deficit if the exercise stimulus is appropriate.
Jose Areta’s study shows strong data of continued muscle adaptation despite energy deficit, though psychological and other physiological effects may differ.
Blinding Is Essential To Test Low Energy Effects On Performance
Jose Areta argues performance effects of low energy availability are confounded by expectation and require blinding to avoid placebo/nocebo bias.
Many studies are unblinded and researchers/participants expecting harm may drive negative results.
